Literature DB >> 17630697

Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors.

Gregory N Prado1, Katsutoshi Suetomi, David Shumate, Carrie Maxwell, Aishwarya Ravindran, Krishna Rajarathnam, Javier Navarro.   

Abstract

Chemokine IL-8 (CXCL8) binds to its cognate receptors CXCR1 and CXCR2 to induce inflammatory responses, wound healing, tumorogenesis, and neuronal survival. Here we identify the N-loop residues in IL-8 (H18 and F21) and the receptor N-termini as the major structural determinants regulating the rate of receptor internalization, which in turn controlled the activation profile of ERK1/2, a central component of the receptor/ERK signaling pathway that dictates signal specificity. Our data further support the idea that the chemokine receptor core acts as a plastic scaffold. Thus, the diversity and intensity of inflammatory and noninflammatory responses mediated by chemokine receptors appear to be primarily determined by the initial interaction between the receptor N-terminus and the N-loop of chemokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630697      PMCID: PMC2727729          DOI: 10.1021/bi7004043

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

Review 1.  Chemokine receptors: signposts to brain development and disease.

Authors:  Phuong B Tran; Richard J Miller
Journal:  Nat Rev Neurosci       Date:  2003-06       Impact factor: 34.870

2.  Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.

Authors:  G J LaRosa; K M Thomas; M E Kaufmann; R Mark; M White; L Taylor; G Gray; D Witt; J Navarro
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

Review 3.  Chemokines, chemokine receptors and small-molecule antagonists: recent developments.

Authors:  James J Onuffer; Richard Horuk
Journal:  Trends Pharmacol Sci       Date:  2002-10       Impact factor: 14.819

4.  Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.

Authors:  Seungkirl Ahn; Sudha K Shenoy; Huijun Wei; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

5.  On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2.

Authors:  Jeremy J Rose; John F Foley; Philip M Murphy; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

6.  The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R.

Authors:  K M Thomas; L Taylor; J Navarro
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

7.  Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.

Authors:  Gwenny M Fuhler; Gerlinde J Knol; A Lyndsay Drayer; Edo Vellenga
Journal:  J Leukoc Biol       Date:  2004-11-23       Impact factor: 4.962

8.  Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.

Authors:  R B Gayle; P R Sleath; S Srinivason; C W Birks; K S Weerawarna; D P Cerretti; C J Kozlosky; N Nelson; T Vanden Bos; M P Beckmann
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

9.  Interleukin-8 antagonists generated by N-terminal modification.

Authors:  B Moser; B Dewald; L Barella; C Schumacher; M Baggiolini; I Clark-Lewis
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

10.  Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.

Authors:  C A Hébert; R V Vitangcol; J B Baker
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

View more
  34 in total

1.  The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes.

Authors:  D I Cho; C Min; K S Jung; S Y Cheong; M Zheng; S J Cheong; M H Oak; J H Cheong; B K Lee; K M Kim
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy.

Authors:  Sang Ho Park; Fabio Casagrande; Leah Cho; Lauren Albrecht; Stanley J Opella
Journal:  J Mol Biol       Date:  2011-10-12       Impact factor: 5.469

3.  Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.

Authors:  Christine J Rossant; Danielle Carroll; Ling Huang; John Elvin; Frances Neal; Edward Walker; Joris J Benschop; Eldar E Kim; Simon T Barry; Tristan J Vaughan
Journal:  MAbs       Date:  2014       Impact factor: 5.857

4.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

Review 5.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

6.  Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.

Authors:  Christian Weber; Sandra Kraemer; Maik Drechsler; Hongqi Lue; Rory R Koenen; Aphrodite Kapurniotu; Alma Zernecke; Jürgen Bernhagen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

Review 7.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

8.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

9.  Adenovirus mediated expression "in vivo" of the chemokine receptor CXCR1.

Authors:  J Sarmiento; K E Kypreos; G N Prado; K Suetomi; C Stanzel; C Maxwell; D Shumate; M R Tandang-Silvas; K Rajarathnam; J Navarro
Journal:  J Struct Funct Genomics       Date:  2008-12-04

10.  Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment.

Authors:  Sandhya Thulasi Das; Lavanya Rajagopalan; Antonieta Guerrero-Plata; Jiqing Sai; Ann Richmond; Roberto P Garofalo; Krishna Rajarathnam
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.